CancerNetwork® was joined by 2 clinicians from Moffitt Cancer Center to discuss why some patients do not respond to CAR T-cell therapy, despite the significant promise of the treatment modality.
Michael Jain, MD, PhD
Advertisement
Articles by Michael Jain, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
How Will ESMO 2025 Data Shape the Future of Genitourinary Cancer Care?
2
Exploring the ESMO 2025 Presentations That May Shift GU Oncology
3
Pembrolizumab/Chemotherapy Improves Survival in Recurrent PROC
4
Teclistamab/SC Daratumumab Improves Survival in R/R Multiple Myeloma
5
